1. Home
  2. PRAX vs CBSH Comparison

PRAX vs CBSH Comparison

Compare PRAX & CBSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.29

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Commerce Bancshares Inc.

CBSH

Commerce Bancshares Inc.

HOLD

Current Price

$51.83

Market Cap

8.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
CBSH
Founded
2015
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.1B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
PRAX
CBSH
Price
$337.29
$51.83
Analyst Decision
Strong Buy
Hold
Analyst Count
15
8
Target Price
$572.13
$58.28
AVG Volume (30 Days)
326.2K
1.2M
Earning Date
05-08-2026
04-21-2026
Dividend Yield
N/A
2.15%
EPS Growth
N/A
4.39
EPS
N/A
4.04
Revenue
N/A
N/A
Revenue This Year
N/A
$17.43
Revenue Next Year
$7,758.26
$3.43
P/E Ratio
N/A
$12.88
Revenue Growth
N/A
N/A
52 Week Low
$34.89
$46.99
52 Week High
$354.87
$66.31

Technical Indicators

Market Signals
Indicator
PRAX
CBSH
Relative Strength Index (RSI) 55.91 57.14
Support Level $282.49 $51.34
Resistance Level $353.83 $54.52
Average True Range (ATR) 18.75 1.06
MACD -0.96 0.11
Stochastic Oscillator 69.67 73.54

Price Performance

Historical Comparison
PRAX
CBSH

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.

Share on Social Networks: